AMPLATZER SEPTAL OCCLUDER
Report
- Report Number
- 2135147-2017-00101
- Event Type
- Injury
- Date Received
- August 30, 2017
- Date of Event
- August 10, 2017
- Report Date
- August 30, 2017
- Manufacturer
- AGA MEDICAL CORPORATION
- Product Code
- MLV
- PMA / PMN Number
- P000039
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THE RESULTS OF THE INVESTIGATION ARE INCONCLUSIVE SINCE THE DEVICE WAS NOT RETURNED FOR ANALYSIS. OUR INVESTIGATION WAS LIMITED TO THE REVIEW OF THE DEVICE HISTORY RECORD, WHICH SHOWED THAT EACH MANUFACTURING AND INSPECTION OPERATION WAS PERFORMED AND INDICATED COMPLETE IN ACCORDANCE WITH ABBOTT SPECIFICATIONS AND PROCEDURES. BASED ON THE INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED.
THE PATIENT HAD A MULTI-FENESTRATED ATRIAL SEPTAL DEFECT (ASD) THAT WAS 5.8 MM AND SECOND THAT WAS 26 MM LOCATED ABOUT 6 MM FROM THE SMALLER DEFECT. ON (B)(6) 2017, AN 8 MM AMPLATZER SEPTAL OCCLUDER (ASO) WAS DEPLOYED FIRST ON THE AORTIC SIDE AND THEN A 27 MM FIGULLA FLEX II: FSO (JAPAN LIFELINE) WAS DEPLOYED OVERLAPPING THE ASO. ON (B)(6), A FOLLOW UP ECHOCARDIOGRAM SHOWED ATRIAL FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA. THE PATIENT WAS ASYMPTOMATIC. THE FSO HAD EMBOLIZED BETWEEN THE LEFT ATRIA AND VENTRICLE. LATER THAT DAY THE FSO AND ASO WERE BOTH SURGICALLY REMOVED. THE MULTI-FENESTRATED ASD WAS CLOSED WITH A PERICARDIAL PATCH AND A MITRAL VALVULOPLASTY WAS PERFORMED. DURING THE PROCEDURE NO ANOMALIES WERE FOUND ON THE ASO. THE PHYSICIAN ALLEGED THE CAUSE OF THE EVENT WAS DUE AN UNDERSIZED FSO.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 611623 | AMPLATZER SEPTAL OCCLUDER | CARDIAC OCCLUSION DEVICE | MLV | AGA MEDICAL CORPORATION | 9-ASD-008 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR |